Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
Designed to provide assistance to early-stage small businesses in a recovering New York State economy, The New York State Seed Funding Grant Program is open to businesses that are currently operational with annual revenues between $5,000 and $1,000,000 that began operation on or after September 1, 2018. Visit nyseedgrant.com for more information.
CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.
The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.
Read more about IAMBIC and their recent funding here.
SBU Startup, Lahara Bio, presented in the start-up stadium event at the 2023 BIO International Convention in June.
Christopher Ashdown, a MD/PhD student at Stony Brook University, and Center for Biotechnology Program alumnus presented on behalf of Lahara after securing a spot in the coveted forum by winning multiple pitch competitions from NIH SEED office.
According to Ashdown, “Bio 2023 was an amazing experience, and I was thrilled to be able to share the exciting work that we're doing at Lahara Bio with the greater bioscience community. The CfB was incredibly helpful in preparing the company for this conference and has done an excellent job of helping me develop on a personal/professional level".
In addition to the main stage presentation, Ashdown also presented Lahara Bio at the NIH booth. Lahara Bio was sponsored to attend BIO by the NIH after Ashdown won the national investor pitch competition at the NIH Proof of Concept Network annual meeting this past spring.
Lahara Bio is an early-stage biotechnology company using cell-specific mechanical vibration to non-invasively improve biomanufacturing outcomes. Learn more about the company and the team behind Lahara at laharabio.com.
[post_title] => Lahara Bio Presents at BIO International Convention
[post_excerpt] => Stony Brook Start Up, Lahara Bio, was presented at the 2023 BIO International Convention by Christopher Ashdown, a MD/PhD student at Stony Brook University, and Center for Biotechnology Program alumnus.
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => lahara-bio-presents-at-bio-international-convention
[to_ping] =>
[pinged] =>
[post_modified] => 2024-08-22 11:32:58
[post_modified_gmt] => 2024-08-22 15:32:58
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4231
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[2] => WP_Post Object
(
[ID] => 3912
[post_author] => 3
[post_date] => 2022-08-22 13:06:25
[post_date_gmt] => 2022-08-22 13:06:25
[post_content] =>
November 2-3, 2022 | Virtual
The Life Sciences Summit is an exclusive early stage investor and business development conference that highlights innovation. The objective of the event is to provide an intimate setting allowing emerging biotech companies and academic innovators to connect with the capital and strategic partners they will need to move new discoveries through clinical development.
The virtual 2022 program features thought provoking plenary sessions, presentations by promising young companies with transformative science, the "innovation pipeline" featuring academic innovators and pre-seed stage companies working on cutting edge technologies, and 1:1 networking opportunities.
[post_title] => Save the Date! LSS 2022
[post_excerpt] => Join the Center for Biotechnology November 2-3 at our Virtual Life Sciences Summit 2022!
[post_status] => publish
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => save-the-date-lss-2022
[to_ping] =>
[pinged] =>
[post_modified] => 2022-12-13 17:04:15
[post_modified_gmt] => 2022-12-13 17:04:15
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=3912
[menu_order] => 23
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 2772
[post_author] => 3
[post_date] => 2017-06-28 12:43:31
[post_date_gmt] => 2017-06-28 12:43:31
[post_content] => Call for Papers: The 13th International Conference & Expo on Emerging Technologies for a Smarter World (CEWIT2017)
November 7 & 8, 2017
The Center of Excellence in Wireless and Information Technology (CEWIT) at Stony Brook University
Stony Brook, NY, USA
www.cewit.org/conference2017
CEWIT2017 is the premier international forum for presentations of original research results as well as the exchange and transfer of innovative, end-to-end solutions, applications, and systems of emerging technologies in infrastructure, healthcare, and energy - three of the most critical components of a smarter global world. Specific topics of interest include but are not limited to, the Internet of Things; Cybersecurity; Big Data Analytics and Visualization; Health Technologies and Medical Devices; Smart Energy; and Smart Urban Systems, as well as Technological Applications and Tech Entrepreneurship.
Organized by the NYSTAR-designated New York State Center of Excellence in Wireless and Information Technology (CEWIT), CEWIT2017 is a destination for researchers, innovators, and entrepreneurs, across borders and disciplines, to exchange ideas, build valuable partnerships, and bring cutting-edge technology to the marketplace. The 2017 program will feature a series of research and entrepreneurial-focused tech talks, workshops, and keynote plenaries at CEWIT's next generation research and educational facility at Stony Brook University.
Abstract Submission Deadline: August 1, 2017
More Information and to Submit Your Contribution:www.cewit.org/conference2017Contact: 631-216-7000; conference@cewit.org
[post_title] => Call for Papers: CEWIT2017
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => call-for-papers-cewit2017
[to_ping] =>
[pinged] =>
[post_modified] => 2017-06-28 12:43:31
[post_modified_gmt] => 2017-06-28 12:43:31
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/?p=2772
[menu_order] => 141
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 4
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 4439
[post_author] => 3
[post_date] => 2024-07-30 15:29:07
[post_date_gmt] => 2024-07-30 19:29:07
[post_content] =>
CFB Client, IAMBIC has been awarded approximately $1M in grant funding from the National Science Foundation Small Business Innovation Research program. IAMBIC is an innovative shoe company disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. This substantial funding from NSF enables IAMBIC to scale its cutting-edge precision-fit shoe design and manufacturing.
The Center for Biotechnology and its accelerator programs have been instrumental in assisting IAMBIC with their SBIR pursuits and commercialization development.
Read more about IAMBIC and their recent funding here.